Literature DB >> 26327714

Caldora penicillata gen. nov., comb. nov. (cyanobacteria), a pantropical marine species with biomedical relevance.

Niclas Engene, Ana Tronholm, Lilibeth A Salvador-Reyes, Hendrik Luesch, Valerie J Paul.   

Abstract

Many tropical marine cyanobacteria are prolific producers of bioactive secondary metabolites with ecological relevance and promising pharmaceutical applications. One species of chemically rich, tropical marine cyanobacteria that was previously identified as Symploca hydnoides or Symploca sp. corresponds to the traditional taxonomic definition of Phormidium penicillatum. In this study, we clarified the taxonomy of this biomedically and ecologically important cyanobacterium by comparing recently collected specimens with the original type material and the taxonomic description of P. penicillatum. Molecular phylogenetic analyses of the 16S rRNA gene and the 16S-23S internal transcribed spacer regions showed that P. penicillatum formed an independent clade sister to the genus Symploca, and distantly related to Phormidium and Lyngbya. We propose the new genus Caldora for this clade, with Caldora penicillata comb. nov. as the type species and designate as the epitype the recently collected strain FK13-1. Furthermore, the production of bioactive secondary metabolites among various geographically dispersed collections of C. penicillata showed that this species consistently produced the metabolite dolastatin 10 and/or the related compound symplostatin 1, which appear to be robust autapomorphic characters and chemotaxonomic markers for this taxon.

Entities:  

Year:  2015        PMID: 26327714      PMCID: PMC4551411          DOI: 10.1111/jpy.12309

Source DB:  PubMed          Journal:  J Phycol        ISSN: 0022-3646            Impact factor:   2.923


  28 in total

1.  MrBayes 3: Bayesian phylogenetic inference under mixed models.

Authors:  Fredrik Ronquist; John P Huelsenbeck
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

2.  Phylogenetic evaluation of cyanobacteria preserved as historic herbarium exsiccata.

Authors:  Katarzyna A Palinska; Christian F Thomasius; Jürgen Marquardt; Stjepko Golubic
Journal:  Int J Syst Evol Microbiol       Date:  2006-10       Impact factor: 2.747

3.  Notes on the characterization of prokaryote strains for taxonomic purposes.

Authors:  B J Tindall; R Rosselló-Móra; H-J Busse; W Ludwig; P Kämpfer
Journal:  Int J Syst Evol Microbiol       Date:  2009-08-21       Impact factor: 2.747

4.  jModelTest: phylogenetic model averaging.

Authors:  David Posada
Journal:  Mol Biol Evol       Date:  2008-04-08       Impact factor: 16.240

5.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

6.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

7.  Biosynthetically intriguing chlorinated lipophilic metabolites from geographically distant tropical marine cyanobacteria.

Authors:  Joshawna K Nunnery; Niclas Engene; Tara Byrum; Zhengyu Cao; Sairam V Jabba; Alban R Pereira; Teatulohi Matainaho; Thomas F Murray; William H Gerwick
Journal:  J Org Chem       Date:  2012-04-19       Impact factor: 4.354

8.  Morphological, chemical, and genetic diversity of tropical marine cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales).

Authors:  Robert W Thacker; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

9.  Horizontal transfer of the nitrogen fixation gene cluster in the cyanobacterium Microcoleus chthonoplastes.

Authors:  Henk Bolhuis; Ina Severin; Veronique Confurius-Guns; Ute I A Wollenzien; Lucas J Stal
Journal:  ISME J       Date:  2009-09-10       Impact factor: 10.302

10.  New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras.

Authors:  Kevin E Ashelford; Nadia A Chuzhanova; John C Fry; Antonia J Jones; Andrew J Weightman
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

View more
  17 in total

Review 1.  Advances in exploring the therapeutic potential of marine natural products.

Authors:  Xiao Liang; Danmeng Luo; Hendrik Luesch
Journal:  Pharmacol Res       Date:  2019-07-25       Impact factor: 7.658

Review 2.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 3.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

4.  Caldoramide, a Modified Pentapeptide from the Marine Cyanobacterium Caldora penicillata.

Authors:  Sarath P Gunasekera; Lorelie Imperial; Christiana Garst; Ranjala Ratnayake; Long H Dang; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2016-07-05       Impact factor: 4.050

5.  Synthesis and biological evaluation of largazole zinc-binding group analogs.

Authors:  Bumki Kim; Ranjala Ratnayake; Hyunji Lee; Guqin Shi; Sabrina L Zeller; Chenglong Li; Hendrik Luesch; Jiyong Hong
Journal:  Bioorg Med Chem       Date:  2017-04-04       Impact factor: 3.641

6.  Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.

Authors:  Ranjala Ratnayake; Sarath P Gunasekera; Jia Jia Ma; Long H Dang; Thomas J Carney; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2020-05-12       Impact factor: 3.164

Review 7.  Marine-Derived Pharmaceuticals - Challenges and Opportunities.

Authors:  Ulrike Lindequist
Journal:  Biomol Ther (Seoul)       Date:  2016-11-01       Impact factor: 4.634

8.  Laucysteinamide A, a Hybrid PKS/NRPS Metabolite from a Saipan Cyanobacterium, cf. Caldora penicillata.

Authors:  Chen Zhang; C Benjamin Naman; Niclas Engene; William H Gerwick
Journal:  Mar Drugs       Date:  2017-04-14       Impact factor: 5.118

Review 9.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

10.  Genome Reduction and Secondary Metabolism of the Marine Sponge-Associated Cyanobacterium Leptothoe.

Authors:  Despoina Konstantinou; Rafael V Popin; David P Fewer; Kaarina Sivonen; Spyros Gkelis
Journal:  Mar Drugs       Date:  2021-05-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.